These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1722 related articles for article (PubMed ID: 26260141)
1. Short-chain fatty acids in control of body weight and insulin sensitivity. Canfora EE; Jocken JW; Blaak EE Nat Rev Endocrinol; 2015 Oct; 11(10):577-91. PubMed ID: 26260141 [TBL] [Abstract][Full Text] [Related]
2. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Morrison DJ; Preston T Gut Microbes; 2016 May; 7(3):189-200. PubMed ID: 26963409 [TBL] [Abstract][Full Text] [Related]
3. Short chain fatty acids in human gut and metabolic health. Blaak EE; Canfora EE; Theis S; Frost G; Groen AK; Mithieux G; Nauta A; Scott K; Stahl B; van Harsselaar J; van Tol R; Vaughan EE; Verbeke K Benef Microbes; 2020 Sep; 11(5):411-455. PubMed ID: 32865024 [TBL] [Abstract][Full Text] [Related]
4. The Short-Chain Fatty Acid Acetate in Body Weight Control and Insulin Sensitivity. Hernández MAG; Canfora EE; Jocken JWE; Blaak EE Nutrients; 2019 Aug; 11(8):. PubMed ID: 31426593 [TBL] [Abstract][Full Text] [Related]
5. Effects of short chain fatty acid producing bacteria on epigenetic regulation of FFAR3 in type 2 diabetes and obesity. Remely M; Aumueller E; Merold C; Dworzak S; Hippe B; Zanner J; Pointner A; Brath H; Haslberger AG Gene; 2014 Mar; 537(1):85-92. PubMed ID: 24325907 [TBL] [Abstract][Full Text] [Related]
6. The interaction of short-chain fatty acids with adipose tissue: relevance for prevention of type 2 diabetes. Roelofsen H; Priebe MG; Vonk RJ Benef Microbes; 2010 Nov; 1(4):433-7. PubMed ID: 21831781 [TBL] [Abstract][Full Text] [Related]
7. Gut microbiota and energy balance: role in obesity. Blaut M Proc Nutr Soc; 2015 Aug; 74(3):227-34. PubMed ID: 25518735 [TBL] [Abstract][Full Text] [Related]
8. Short-chain fatty acids and inulin, but not guar gum, prevent diet-induced obesity and insulin resistance through differential mechanisms in mice. Weitkunat K; Stuhlmann C; Postel A; Rumberger S; Fankhänel M; Woting A; Petzke KJ; Gohlke S; Schulz TJ; Blaut M; Klaus S; Schumann S Sci Rep; 2017 Jul; 7(1):6109. PubMed ID: 28733671 [TBL] [Abstract][Full Text] [Related]
9. [Host energy regulation via SCFAs receptors, as dietary nutrition sensors, by gut microbiota]. Kimura I Yakugaku Zasshi; 2014; 134(10):1037-42. PubMed ID: 25274213 [TBL] [Abstract][Full Text] [Related]
10. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. Sun M; Wu W; Liu Z; Cong Y J Gastroenterol; 2017 Jan; 52(1):1-8. PubMed ID: 27448578 [TBL] [Abstract][Full Text] [Related]
11. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Diamant M; Blaak EE; de Vos WM Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522 [TBL] [Abstract][Full Text] [Related]
12. Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders. Gill PA; van Zelm MC; Muir JG; Gibson PR Aliment Pharmacol Ther; 2018 Jul; 48(1):15-34. PubMed ID: 29722430 [TBL] [Abstract][Full Text] [Related]
13. Dietary Fiber, Gut Microbiota, and Metabolic Regulation-Current Status in Human Randomized Trials. Myhrstad MCW; Tunsjø H; Charnock C; Telle-Hansen VH Nutrients; 2020 Mar; 12(3):. PubMed ID: 32210176 [TBL] [Abstract][Full Text] [Related]
15. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976 [TBL] [Abstract][Full Text] [Related]
16. Supplementation of a propionate-producing consortium improves markers of insulin resistance in an in vitro model of gut-liver axis. El Hage R; Hernandez-Sanabria E; Calatayud Arroyo M; Van de Wiele T Am J Physiol Endocrinol Metab; 2020 May; 318(5):E742-E749. PubMed ID: 31935110 [TBL] [Abstract][Full Text] [Related]
17. Insulin Sensitivity-Enhancing Activity of Phlorizin Is Associated with Lipopolysaccharide Decrease and Gut Microbiota Changes in Obese and Type 2 Diabetes (db/db) Mice. Mei X; Zhang X; Wang Z; Gao Z; Liu G; Hu H; Zou L; Li X J Agric Food Chem; 2016 Oct; 64(40):7502-7511. PubMed ID: 27635781 [TBL] [Abstract][Full Text] [Related]
18. The role of microbial amino acid metabolism in host metabolism. Neis EP; Dejong CH; Rensen SS Nutrients; 2015 Apr; 7(4):2930-46. PubMed ID: 25894657 [TBL] [Abstract][Full Text] [Related]
19. Circulating but not faecal short-chain fatty acids are related to insulin sensitivity, lipolysis and GLP-1 concentrations in humans. Müller M; Hernández MAG; Goossens GH; Reijnders D; Holst JJ; Jocken JWE; van Eijk H; Canfora EE; Blaak EE Sci Rep; 2019 Aug; 9(1):12515. PubMed ID: 31467327 [TBL] [Abstract][Full Text] [Related]